Sarcopenia: revised European consensus on definition and diagnosis

Clicks: 6
ID: 289188
2018
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #22 of 50 articles by views in age and ageing

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
in 2010, the European Working Group on Sarcopenia in Older People (EWGSOP) published a sarcopenia definition that aimed to foster advances in identifying and caring for people with sarcopenia. In early 2018, the Working Group met again (EWGSOP2) to update the original definition in order to reflect scientific and clinical evidence that has built over the last decade. This paper presents our updated findings. to increase consistency of research design, clinical diagnoses and ultimately, care for people with sarcopenia. sarcopenia is a muscle disease (muscle failure) rooted in adverse muscle changes that accrue across a lifetime; sarcopenia is common among adults of older age but can also occur earlier in life. In this updated consensus paper on sarcopenia, EWGSOP2: (1) focuses on low muscle strength as a key characteristic of sarcopenia, uses detection of low muscle quantity and quality to confirm the sarcopenia diagnosis, and identifies poor physical performance as indicative of severe sarcopenia; (2) updates the clinical algorithm that can be used for sarcopenia case-finding, diagnosis and confirmation, and severity determination and (3) provides clear cut-off points for measurements of variables that identify and characterise sarcopenia. EWGSOP2's updated recommendations aim to increase awareness of sarcopenia and its risk. With these new recommendations, EWGSOP2 calls for healthcare professionals who treat patients at risk for sarcopenia to take actions that will promote early detection and treatment. We also encourage more research in the field of sarcopenia in order to prevent or delay adverse health outcomes that incur a heavy burden for patients and healthcare systems.
Reference Key
openalex_W2897513125 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Alfonso J. Cruz‐Jentoft, Gülistan Bahat, Jürgen M. Bauer, Yves Boirie‌, Olivier Bruyère, Tommy Cederholm, Cyrus Cooper, Francesco Landi, Yves Rolland, Avan Aihie Sayer, S. Schneider, Cornel Sieber, Eva Topinková, M. Vandewoude, Marjolein Visser, Mauro Zamboni, Ivan Bautmans, Jean‐Pierre Baeyens, Matteo Cesari, Antonio Cherubini, John А. Kanis, Marcello Maggio, Finbarr C. Martin, Jean‐Pierre Michel, Kaisu Pitkälä, Jean‐Yves Reginster, René Rizzoli, Dolores Sánchez‐Rodríguez, Jos M. G. A. Schols
Journal age and ageing
Year 2018
DOI
10.1093/ageing/afy169
URL
https://academic.oup.com/ageing/article-pdf/48/1/16/28605038/afy169.pdf
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.